Publication, Part of Case-mix Adjusted Percentage of Cancers Diagnosed at Stages 1 and 2 in England
Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 by sub-ICB in England, 2021
Official statistics
Summary
This publication presents the 1- and 3- year unadjusted and case-mix adjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator nationally and at sub-Integrated Care Board (sub-ICB) level. The most recently available results are for cancers diagnosed in 2021, with data available from 2013. The unadjusted percentage of cancers diagnosed at each stage is also provided by cancer site/group and deprivation quintile. It also presents the 1-year rolling unadjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator (known as the ‘75% ambition’ indicator) nationally and at Cancer Alliance level, for 2013 to 2021.
Key Facts
The unadjusted percentage of cancers diagnosed at stages 1 and 2 returned to pre-pandemic levels in 2021
54% of cancers with a valid stage were diagnosed at stages 1 and 2 in 2021, which is the same as in 2019 (54%) and higher than in 2020 (52%)
Part of the variation in the percentage of cancers diagnosed at stages 1 and 2 between sub-ICBs is associated with population characteristics
Case-mix adjusted percentages across the 106 sub-ICBs range from 50% to 58% in 2019 to 2021, which is smaller than the unadjusted range (48% to 59%)
The unadjusted percentage of cancers diagnosed at stages 1 and 2 is lower in areas with higher deprivation
The unadjusted percentage of cancers diagnosed at stages 1 and 2 in the 20% most deprived areas of England is 8 percentage points lower than for those in the 20% least deprived areas
The unadjusted percentage of cancers diagnosed at stages 1 and 2 varied by cancer site
This ranged from 19% (Oesophagus including cardia and gastroesophageal junction) to 90% (testis)
Previous releases of these statistics can be found at the link below.
Acknowledgements
This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Disease Registration Service, which is part of NHS Digital.
Resources
Last edited: 14 December 2023 9:47 am